Status
Conditions
About
The purpose of this study is to measure the level of AlloMax™ incorporation (cellular infiltration, collagen production, and neovascularization) in human breast reconstruction. The hypothesis is that the AlloMaxTM will have incorporation equivalent to adjacent breast capsule at the 3-4 month time point.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
60 participants in 3 patient groups
Loading...
Central trial contact
Shelley J Williams, M.S.; Kayvan Taghipour-Khiabani, M.D.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal